Clinical Trial Update: Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients [Phase 4]

View source ↗

Summary

Pfizer conducted a Phase 4 safety study to assess opiate withdrawal signs and symptoms in opioid-dependent patients with chronic pain, but the study was termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Pain

Snippet

Sponsor: Pfizer | Conditions: Chronic Pain | Phase 4 | Status: TERMINATED | Results posted: 2012-03-28